Salt-losing Androgenital syndrome

Drug	Drug Name	Drug Description
DB00687	Fludrocortisone	A mineralocorticoid used to treat adrenocortical insufficiency and salt-losing adrenogenital syndrome.

Drug	Drug Name	Target	Type
DB00687	Fludrocortisone	Mineralocorticoid receptor	target
DB00687	Fludrocortisone	Glucocorticoid receptor	target
DB00687	Fludrocortisone	Cytochrome P450 3A4	enzyme
DB00687	Fludrocortisone	Corticosteroid 11-beta-dehydrogenase isozyme 2	enzyme
DB00687	Fludrocortisone	Corticosteroid 11-beta-dehydrogenase isozyme 1	enzyme
DB00687	Fludrocortisone	Serum albumin	carrier
DB00687	Fludrocortisone	Corticosteroid-binding globulin	carrier

Drug	Drug Name	Phase	Status	Count